The Claim
In adults with resistance to thyroid hormone β, TRIAC therapy is associated with no significant change in sleeping heart rate or plasma NT-proBNP levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with resistance to thyroid hormone β, treatment with TRIAC does not alter sleeping heart rate or plasma NT-proBNP levels.
See the scientific wording
In adults with resistance to thyroid hormone β, TRIAC therapy is associated with no significant change in sleeping heart rate or plasma NT-proBNP levels, suggesting it does not exacerbate cardiac thyromimetic activity despite lowering thyroid hormone levels.
TRIAC binds to defective thyroid hormone receptors in the brain, which tells the pituitary to stop signaling the thyroid to make excess hormones. This lowers the amount of thyroid hormone in the blood. The reduced hormone levels decrease metabolic activity in the body, but TRIAC itself does not activate heart receptors, so the heart rate and heart stress markers stay unchanged.
What the research says
1 studyIn people with a thyroid hormone resistance condition, TRIAC helped reduce symptoms and lower thyroid hormone levels without making their heart beat faster or putting extra stress on it, which means it’s safe for the heart.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.